Reply to Itzhaki

Authors:

Abstract
To the Editor—We thank Drs Itzhaki and Klapper for their interest in and comments regarding our study [1], which examined the relationship between cytomegalovirus (CMV) infection and risk of Alzheimer's disease (AD). We found that CMV seropositivity was associated with a 2-fold increase in risk of AD and a faster rate of cognitive decline. The results were robust to a number of covariates, including herpes simplex virus type 1 (HSV-1). In addition, our findings support earlier cohort studies that have examined the association between CMV and cognitive function [2, 3]. Together, these studies suggest a potential role for CMV as a factor that may influence cognition and risk of AD in older ages.